Navigation Links
Isis Pharmaceuticals (Nasdaq: ISIS) Letter to Shareholders
Date:11/23/2009

CARLSBAD, Calif., Nov. 23 /PRNewswire-FirstCall/ --

Dear Isis Supporters and Shareholders,

I would like to start by thanking you for your continuing support of Isis. We believe we are at one of the most successful moments in our history. We are truly at the end of the beginning of creating a unique company with a novel drug discovery platform, which we believe addresses many of the issues haunting the pharmaceutical industry.

Our progress is predicated largely upon the success of our flagship drug, mipomersen. Mipomersen continues to perform well and progress toward commercialization. Isis, our investigators and members of the medical community are very encouraged by the results that were presented at the AHA last week. To get a sense of their support of the drug, I would encourage you to listen to the replay of the mipomersen investigator panel presentation that was conducted during AHA last week. I think you will hear not only their enthusiasm for the drug but their hope that mipomersen will provide a new treatment alternative for their patients at very high risk of cardiovascular disease.

We are disappointed with the reaction on Wall Street to what we believe is very positive news. We believe mipomersen will continue to provide results that speak for themselves. Each success brings us closer to getting mipomersen to the market and making the drug available to patients in need.

Our antisense technology provides a direct route from genes to drugs with the opportunity to dramatically improve the productivity of the pharmaceutical industry. With 19 drugs in development, we have one of the largest and most diverse pipelines in our industry. We know that sick people depend on us. We continue to strive for excellence as we create drugs for the future. We also recognize that behind our successes is the support we receive from you. I would like to personally thank you for that.


'/>"/>
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Poniard Pharmaceuticals to Host Conference Call and Webcast at 8:00 a.m. Eastern Time Tomorrow to Discuss Results of Pivotal Phase 3 SPEAR Trial in Small Cell Lung Cancer
2. Jiangbo Pharmaceuticals to Present at Brean Murray, Carret 2009 China Growth Conference
3. Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results
4. Onyx Pharmaceuticals Reports Third Quarter 2009 Financial Results; Nexavar Global Net Sales Top $229 Million, 27% Increase Over Third Quarter 2008
5. Cumberland Pharmaceuticals to Present at Lazard Healthcare Conference in New York on November 17, 2009
6. Vanda Pharmaceuticals Reports Third Quarter 2009 Results
7. Amylin Pharmaceuticals and Takeda Enter into Worldwide Agreement to Co-Develop and Commercialize Compounds for Obesity
8. VIA Pharmaceuticals Featured at Cambridge Healthtech Institute Discovery on Target 2009 Conference
9. Vanda Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 2, 2009
10. Amira Pharmaceuticals to Present at the BIO Investor Forum in San Francisco
11. Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Glycemic Parameters and was not Associated with Depression or Suicidal Ideation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... July 25, 2014 Mahendra Trivedi and ... Online Workshop ‘Consciousness is Power’ on Saturday, July 26, ... to attend this life transforming event as they will ... higher level. Few days are left for the commencement ... Trivedi and Trivedi Masters™ Dahryn Trivedi (his wife) and ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 ... review recently updated by Vkool.com, this is ... how to treat some common types of ... and internal hemorrhoids ,     Young children ... with hemorrhoids ,     Very large hemorrhoids ...
(Date:7/25/2014)... 25, 2014 According to the ... updated by Vkool.com, this is a comprehensive guide ... natural and safe remedies for liver cirrhosis ... including:,     Chapter 1: Liver Cirrhosis ... 2: Learn About Liver Basics ,     Chapter ...
(Date:7/24/2014)... (PRWEB) July 25, 2014 Journal ... be affected by the width of the alveolar ridge—an ... the implant. A variety of methods exist, each with ... augmentation techniques. The ridge-split graft is highlighted as a ... Journal of Oral Implantology offers a comparison of ...
(Date:7/24/2014)... [Brown University] The U.S. Preventive Services Task ... for people at high risk for cancer, but ... patients will have positive results on the screening ... testing. Many policymakers have expressed concern that this ... needlessly upset. A new study of National Lung ...
Breaking Medicine News(10 mins):Health News:Mahendra Trivedi to Host an Online Workshop ‘Consciousness is Power’ 2Health News:Mahendra Trivedi to Host an Online Workshop ‘Consciousness is Power’ 3Health News:Hemorrhoid No More Pdf Review Exposes Jessica Wright's Guide For Treating Hemorrhoids – Vkool.com 2Health News:Hemorrhoid No More Pdf Review Exposes Jessica Wright's Guide For Treating Hemorrhoids – Vkool.com 3Health News:Liver Cirrhosis Bible & Ezra Protocol Review Exposes Debra Elkin's Liver Cirrhosis Treatment Guide – Vkool - Better Information, Better Lives 2Health News:Liver Cirrhosis Bible & Ezra Protocol Review Exposes Debra Elkin's Liver Cirrhosis Treatment Guide – Vkool - Better Information, Better Lives 3Health News:A Comparison of Graft Techniques for the Alveolar Ridge Prior to Oral Implant 2Health News:A Comparison of Graft Techniques for the Alveolar Ridge Prior to Oral Implant 3Health News:Informed consent: False positives not a worry in lung cancer study 2Health News:Informed consent: False positives not a worry in lung cancer study 3
... in Awareness and Treatment of Mental Disorders Will Drive China,s ... According to a New Report From Decision Resources , ... Decision Resources, one of the world,s leading research and advisory ... views on mental disorders are improving but challenges remain. According ...
... Dec. 11 HairRemovalForum.com, a leading provider of hair removal ... new features to make it easier for guests to locate ... , In recent weeks, Hair ... allowing guests to research service providers in a number of ...
... there are no easy discounts because of where you live or ... money is totally out of your control.  Here are a few ... -  Do the Math: While a plan with a lower ... generally come with either higher co-pays (the part you pay out-of-pocket ...
... Launch extends range of treatment options and empowers wound care professionals ... the patient, the wound and the care setting. , ... Advanced Wound Management Division of Smith & Nephew (LSE: SN; NYSE: ... a foam dressing kit for Negative Pressure Wound Therapy (NPWT). ...
... Greater Access to Renal Function and MetLyte 8 Panels ... UNION CITY, Calif., Dec. 11 Abaxis, Inc. ... manufacturing point-of-care blood analysis systems, today announced that the ... status under CLIA regulations for two additional analytes, Creatine ...
... for commissioned insurance sales agents in Canada are on the rise ... ... Despite recent reports by Statistics Canada that unemployment is growing and ... of supplemental insurance, reports job opportunities for commissioned insurance sales agents ...
Cached Medicine News:Health News:China's Views on Mental Disorders Improving but Challenges Remain 2Health News:China's Views on Mental Disorders Improving but Challenges Remain 3Health News:Hair Removal Forum Unveils New 'Doctor Finder' Interface 2Health News:How to Save Money on Health Insurance 2Health News:Introducing the Smith & Nephew Foam Dressing Kit 2Health News:Introducing the Smith & Nephew Foam Dressing Kit 3Health News:Introducing the Smith & Nephew Foam Dressing Kit 4Health News:Abaxis Point-of-Care Test Panels Gain FDA CLIA-Waived Status 2Health News:Abaxis Point-of-Care Test Panels Gain FDA CLIA-Waived Status 3Health News:Abaxis Point-of-Care Test Panels Gain FDA CLIA-Waived Status 4Health News:Insurance Job Opportunities Rise in Canada in Spite of Challenging Economy 2Health News:Insurance Job Opportunities Rise in Canada in Spite of Challenging Economy 3
(Date:7/24/2014)... , July 24, 2014 Consolidated Net Profit ... Business Highlights   , India Business grew by ... 9.33% to Rs. 4,886.70 Mn Rest of World (ROW) ... Formulations Business grew by 34.53% to Rs. 977.26 Mn ... Glenmark Pharmaceuticals Limited, the research-led global integrated ...
(Date:7/24/2014)... Tenn. , July 24, 2014  In any ... one in 25 patients has at least one hospital-acquired ... Prevention. What,s more, many of these infections prove fatal. ... causing an alarming number of patient deaths per year, ... industry conversation. Consequently, a stronger emphasis ...
(Date:7/24/2014)... 24, 2014 /PRNewswire-iReach/ -- Delivery of the Report ... placed. Photo - http://photos.prnewswire.com/prnh/20140723/129707 ... in-depth market survey on Global and Chinese Hemodialysis ... information of Hemodialysis Machine including its classification, application ... and China,s top manufacturers of Hemodialysis Machine listing ...
Breaking Medicine Technology:Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 2Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 3Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 4Employees, Equipment and the Environment: Top Infection Prevention Focuses in Hospitals 2Employees, Equipment and the Environment: Top Infection Prevention Focuses in Hospitals 3Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 2Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 3Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 4Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 5
... Simcere Pharmaceutical Group (NYSE: SCR ), a ... marketing of branded generic and proprietary pharmaceuticals in China, ... results for the first quarter ended March 31, 2011 ... in the United States. Simcere,s management will host an ...
... 25, 2011 Leading events organiser UBM Live ... its CPhI, ICSE, P-MEC and BioPh Japan events in Tokyo ... the events have now been rescheduled and will be held ...  The Japanese business community is intent on picking itself up ...
Cached Medicine Technology:Simcere Pharmaceutical Group to Announce First Quarter 2011 Financial Results on Tuesday, May 10, 2011 2Boost For Japanese Pharma Market as UBM Announces Rescheduled Japan Pharma and Bio Events 2Boost For Japanese Pharma Market as UBM Announces Rescheduled Japan Pharma and Bio Events 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: